Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Uptake of Comprehensive Eye Examination Trial

This study has been completed.
Sponsor:
Collaborators:
Orbis
The World Diabetes Foundation
Information provided by (Responsible Party):
Congdon Nathan, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT01743781
First received: November 21, 2012
Last updated: January 3, 2014
Last verified: January 2014

November 21, 2012
January 3, 2014
July 2013
September 2013   (final data collection date for primary outcome measure)
The acceptance rate of comprehensive eye examination in both groups [ Time Frame: 1 day ] [ Designated as safety issue: No ]
acceptance rate of comprehensive eye examination
The acceptance rate of comprehensive eye examination in both groups [ Time Frame: 1 week after in hospital eye clinic ] [ Designated as safety issue: No ]
acceptance rate of comprehensive eye examination
Complete list of historical versions of study NCT01743781 on ClinicalTrials.gov Archive Site
knowledges of eye disease and attitude of eye examination [ Time Frame: 1 day ] [ Designated as safety issue: No ]
knowledges of eye disease and attitude of eye examination
knowledges of eye disease and attitude of eye examination [ Time Frame: 1 week after in hospital eye clinic ] [ Designated as safety issue: No ]
knowledges of eye disease and attitude of eye examination
Not Provided
Not Provided
 
Uptake of Comprehensive Eye Examination Trial
The Impact of Multimedia Education on Uptake of Comprehensive Eye Examination in Rural Southern China:A Randomized, Controlled Trial
  1. To evaluate a educational intervention promoting acceptance of comprehensive eye examination in rural Guangdong.
  2. To evaluate the impact of acceptance of comprehensive eye examination in rural Guangdong.

A comprehensive eye examination includes visual acuity, slitlamp exam, pupil exam, intraocular pressure, gonioscope lens and 90D lens with slitlamp exam fundus. A number of eye diseases are irreversible at on early stage. Both glaucoma and diabetic retinopathy(DR)are frequently asymptomatic until significant, often-irreversible, damage to the vision has already occurred. It has been estimated that only 10% of persons in India with glaucoma are diagnosed, and the Handan Eye Survey reports that only 10% of persons with diabetes in rural areas of China have received diabetic eye care. In order to deliver effective care for DR and glaucoma in areas with limited resources, education of patients and interventions to promote compliance among patients will both be needed.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
  • Glaucoma
  • Diabetic Retinopathy
Behavioral: video
view a 10-minute informational video about comprehensive eye examination
  • Experimental: intervention group
    view a 10-minute informational video about comprehensive eye examination
    Intervention: Behavioral: video
  • No Intervention: control group
    No intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
459
September 2013
September 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • age ≥40 years who have never had a comprehensive eye examination

Exclusion Criteria:

  • inability to join informed consent
Both
40 Years and older
No
Contact information is only displayed when the study is recruiting subjects
China
 
NCT01743781
ZOC-CREST2
No
Congdon Nathan, Sun Yat-sen University
Sun Yat-sen University
  • Orbis
  • The World Diabetes Foundation
Principal Investigator: Nathan Congdon, MD,MPH Sun yat-sen university, Zhongshan Ophthalmic Center
Principal Investigator: Mingguang He, MD,PHD Sun Yat-sen University,Zhongshan Ophthalmic Center
Principal Investigator: Aihua Dan, MD Sun Yat-sen University,Zhongshan Ophthalmic Center
Sun Yat-sen University
January 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP